Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medical Cannabis Company Raising $225 Million for Expansion

Stockhouse Editorial
0 Comments| June 7, 2018

{{labelSign}}  Favorites
{{errorMessage}}

Canadian medical marijuana producer Aphria Inc. (TSX: APH, OTCQB: APHQF, Forum) reported Thursday that it will be able to process more than 200 tonnes of cannabis annually.

This comes from a new $55 million facility the Company is planning to build to produce concentrated products, such as oils. APH is raising $225 million to pay for this and other new cannabis facilities, as well as expanding existing operations and potential global expansion and acquisitions.

Aphria entered into an agreement with Clarus Securities Inc., which has agreed to purchase, on a “bought deal” basis, 18,987,400 common shares of the Company at a price of $11.85.

After announcing the news on Wednesday, APH shares closed up 63 cents to $12.79.



{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company